A.JaeschkeH
In a groundbreaking clinical study that was executed for a CELLg8 client, 27 individuals were tested to evaluate the efficacy of CELLg8 Liposomal and CELLg8 Water Dispersible NAD+ supplements
That statement has drawn a lot of criticism because, as other researchers rightly point out, we lack the human safety data and "to date, no published in vivo data demonstrate that BPC 157 inhibits tumor progression, reduces tumor volume, or suppresses metastasis" [16]
Reduce inflammation and relieve pain: Research suggests BPC-157 can alleviate pain in the joints and inflammation (3)
Hagenaars SP, Coleman JRI, Choi SW, Gaspar H, Adams MJ, Howard DM, et al